DUBLIN – Biontech AG is bolstering its antibody discovery capabilities by acquiring the antibody generation unit of its erstwhile partner, Mab Discovery GmbH, for an undisclosed sum. Mainz, Germany-based Biontech gains an 18-person unit, based in Munich, as well as the assets and know-how required to generate antibodies from Mab Discovery's rabbit-based antibody discovery platform.